Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers

NCT01027182 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Raltegravir

Sponsor

Changi General Hospital

Collaborators

[object Object]
[object Object]